CompletedNot Applicable

Soft Coagulation for the Prevention of Adenoma Recurrence

Australia455 participantsStarted 2013-07

Plain-language summary

Recurrence after endoscopic mucosal resection of laterally spreading lesions (LSL) \>= 20mm in size occurs in approximately 20% of cases at surveillance colonoscopy. We aim to evaluate the efficacy of prophylactic adjuvant thermal ablation of the EMR mucosal defect margin in reducing adenoma recurrence following colonic EMR.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Referred for removal of a colonic polyp \>= 20mm in size * Able to give informed consent to involvement in trial Exclusion Criteria: * Younger than 18 years of age * Highly dependant on medical care * Women who are pregnant or may be pregnant. * Taken clopidogrel within 7 days * Taken warfarin within 5 days * Had full therapeutic dose unfractionated heparin within 6 hours * Had full therapeutic dose low molecular weight heparin (LMWH) within 12 hours * Known clotting disorder * Previous attempt at EMR of the polyp referred for resection * Polyp located at the ileo-caecal valve, appendiceal orifice * Fully circumferential polyp * Incomplete snare resection of the polyp

What they're measuring

Endoscopic recurrence

Timeframe: 4-6 months and 18 months

Trial details

NCT IDNCT01789749

SponsorProfessor Michael Bourke

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-05-16

View on ClinicalTrials.gov More Colonic Adenomas trials